Zhongguo Dang Dai Er Ke Za Zhi. 2023 Jan 15;25(1):1-4. doi: 10.7499/j.issn.1008-8830.2212074.
Since the global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2020, the virus has been evolving through mutations to acquire enhanced infectivity but reduced virulence. With a wide vaccination coverage among Chinese population, China is entering a new stage of SARS-CoV-2 infection control. The Working Group for the Prevention and Control of Neonatal SARS-CoV-2 Infection in the Perinatal Period of the Editorial Committee of released the first and second editions of perinatal and neonatal management plan for prevention and control of SARS-CoV-2 infection in January and March 2020, respectively. In order to follow up new prevention and control needs, it is necessary to update the management plan to better guide clinical practice. Therefore, the Working Group formulated the 3rd-edition plan.
自2020年全球严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行以来,该病毒一直在通过突变进化,以获得更强的传染性但降低毒力。随着中国人群广泛接种疫苗,中国正进入新冠病毒感染防控的新阶段。《》编辑委员会围产期新生儿新型冠状病毒感染预防控制工作组分别于2020年1月和3月发布了第一版和第二版围产期及新生儿新型冠状病毒感染防控管理预案。为跟进新的防控需求,有必要更新管理预案以更好地指导临床实践。因此,工作组制定了第3版预案。